MDNC — Medinotec Income Statement
0.000.00%
Last trade - 00:00- $58.67m
- $57.08m
- $5.02m
Annual income statement for Medinotec, fiscal year end - February 29th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1.04 | 1 | 5.02 |
| Cost of Revenue | |||
| Gross Profit | 0.455 | 0.582 | 2.44 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 1.23 | 1.46 | 5.06 |
| Operating Profit | -0.191 | -0.465 | -0.041 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.189 | -0.391 | -0.254 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.124 | -0.353 | -0.405 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.124 | -0.353 | -0.405 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.124 | -0.353 | -0.405 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.011 | -0.03 | 0.001 |
| Dividends per Share |